Inventor
ELOKDAH HASSAN MAHMOUD
US28 patents
⚠️ This page may combine multiple inventors who share the name “ELOKDAH HASSAN MAHMOUD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
WYETH CORP
23 patentsUS6800654B2Oct 5, 2004
Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
WYETH CORP75 citations96
US7074817B2Jul 11, 2006
Substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
WYETH CORP17 citations90
US6589970B2Jul 8, 2003
6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
WYETH CORP20 citations89
US7101903B2Sep 5, 2006
Substituted dihydropyrano indole-3,4-dione derivatives as inhibitiors of plasminogen activator inhibitor-1 (PAI-1)
WYETH CORP13 citations84
US7056943B2Jun 6, 2006
Substituted indole oxo-acetyl amino acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
WYETH CORP12 citations83
US7351730B2Apr 1, 2008
Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
WYETH CORP11 citations82
US6939886B2Sep 6, 2005
Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor Type-1 (PAI-1)
WYETH CORP8 citations72
US6599925B2Jul 29, 2003
Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
WYETH CORP12 citations72
US7411064B2Aug 12, 2008
1-Heterocyclylalkyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands
WYETH CORP3 citations62
US7351726B2Apr 1, 2008
Substituted oxadiazolidinediones
WYETH CORP3 citations62
US7291639B2Nov 6, 2007
Aryloxy-acetic acid compounds useful as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
WYETH CORP5 citations62
US7057039B2Jun 6, 2006
1-heterocyclylalkyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands
WYETH CORP4 citations62
US7420083B2Sep 2, 2008
Substituted aryloximes
WYETH CORP3 citations61
US7342039B2Mar 11, 2008
Substituted indole oximes
WYETH CORP4 citations61
US7259182B2Aug 21, 2007
Aryl, aryloxy, and aklyloxy substituted 1H-indol-3-yl glyoxylic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
WYETH CORP3 citations61
US7163954B2Jan 16, 2007
Substituted naphthyl benzothiophene acids
WYETH CORP2 citations61
US7534894B2May 19, 2009
Biphenyloxy-acids
WYETH CORP6 citations60
US7414051B2Aug 19, 2008
Substituted-dihydro[1,4]oxazino[2,3,4-hi]indazole derivatives as 5-hydroxytryptamine-6 ligands
WYETH CORP2 citations59
US7501421B2Mar 10, 2009
Benzoxazole and benzothiazole derivatives as 5-hydroxytryptamine-6 ligands
WYETH CORP1 citations52
US7629377B2Dec 8, 2009
Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
WYETH CORP0 citations51
US7446201B2Nov 4, 2008
Substituted heteroaryl benzofuran acids
WYETH CORP1 citations51
US7482461B2Jan 27, 2009
Sulfonyl-3-heterocyclylindazole derivatives as 5-hydroxytryptamine-6 ligands
WYETH CORP0 citations49
US7429582B2Sep 30, 2008
Dihydro[1,4]oxazino[2,3,4-hi]indazole derivatives as 5-hydroxytryptamine-6 ligands and use thereof in the treatment of attention deficit disorders
WYETH CORP0 citations38
WYETH LLC
3 patentsUS7674818B2Mar 9, 2010
Aryl, aryloxy, alkyloxy substituted 1H-indol-3-yl glyoxylic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
WYETH LLC1 citations51
US7723329B2May 25, 2010
Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands
WYETH LLC1 citations47
US7790751B2Sep 7, 2010
Azinyl-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands
WYETH LLC0 citations38